Novalis LifeSciences Investments
Startup rounds since 2016 with a Novalis LifeSciences Investments investor on the board, and the firm's own fund filings.
Raises
29
since 2016
Unannounced
3
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name
Rounds
- Everest Biolabs, Inc.$4.35M
- Flywheel Exchange Inc.$16.4M
- Flywheel Exchange Inc.$2.25M
- BlueWhale Bio, Inc.$5M
- Flywheel Exchange Inc.$20M
- Animol Discovery, Inc.$4M
- Ambient Biosciences, Inc.$4.16M
- Kumanu, Inc.$435K
- LevitasBio, Inc.$11.8M
- LumaCyte, Inc.$10M
- Telesis Bio Inc.$28M
- Kumanu, Inc.$1.96M
- Upkara Inc.$9.15M
- Enko Chem, Inc.$80M
- LevitasBio, Inc.$35M
- Animol Discovery, Inc.$32M
- Vizgen, Inc.$85.2M
- ACTIV Surgical, Inc.$14.6M
- LumaCyte, Inc.$6.78M
- Arbor Biotechnologies, Inc.$215M
- ACTIV Surgical, Inc.$40.6M
- Vizgen, Inc.$37M
- Mercy BioAnalytics, Inc.$27.3M
- ACTIV Surgical, Inc.$15M
- Kumanu, Inc.$3M
- Enko Chem, Inc.$39.7M
- Kumanu, Inc.$6.25M
- Quanterix Corp$8.5M
- Quanterix Corp$45.6M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 1 | 1 |
| 2025 | 4 | 2 |
| 2024 | 4 | — |
| 2023 | 4 | — |
| 2022 | 6 | — |
| 2021 | 4 | — |
| 2020 | 3 | — |
| 2019 | 1 | — |
| 2017 | 1 | — |
| 2016 | 1 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Novalis LifeSciences Investments II, L.P. | 29 Mar 2022 | Open-ended | $297M |
Listed because a Novalis LifeSciences Investments fund's filing names a director of each company. A name match is not a verified identity.